A REVIEW OF ANTI-VEGF AGENTS FOR PROLIFERATIVE DIABETIC RETINOPATHY
Journal: International Journal of Advanced Research (Vol.11, No. 01)Publication Date: 2023-01-18
Authors : Avinash S. Ghaytadak; Kashinath G. Choudhary;
Page : 663-669
Keywords : Diabetic Retinopathy Diabetic Macular Edema Proliferative Diabetic Retinopathy Vascular Endothelial Growth Factor;
Abstract
Diabetic retinopathy (DR) is commonly known among diabetic patients, which causes blindness. Proliferative diabetic retinopathy (PDR) and macular edema are the most common complications of DR that adversely impact the vision. Many observational and preclinical studies have implicated vascular endothelial growth factor (VEGF) in the pathogenesis of DR, and recent successes with anti-VEGF therapy for age-related macular degeneration (AMD) have prompted research into the application of anti-VEGF drugs to DR. Here we review the numerous early studies that suggest an important potential role for anti-VEGF agents in the management of diabetic retinopathy.
Other Latest Articles
- COMPARATIVE EFFICIENCY MEASUREMENT OF THE SELECTED GARMENTS FACTORIES IN BANGLADESH: AN APPLICATION OF DATA ENVELOPMENT ANALYSIS (DEA)
- PSYCHOTRAUMA AND CLINICALPOLYMORPHISM : CASE REPORT
- LEVEL OF WORK PERFORMANCE AND WORK ENGAGEMENT OFEMPLOYEES IN THE CITY GOVERNMENT OFGENERAL SANTOS
- IMPETIGO HERPETIFORMIS IN A CASE REPORTPRESENTATION OF A RARE ENTITY
- CLINICOPATHOLOGICAL SPECTRUM OF BENIGN ORAL CAVITY LESIONS
Last modified: 2023-02-08 19:17:14